The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...
A December recall on Lay’s Potato Chips sold in two states has been escalated to the FDA’s highest risk level, but no ...
The Alabama Department of Public Health (ADPH) is investigating reports of adverse reactions to injections of the antibiotic ...
Two seasoning products have been recalled nationwide because of concerns they could cause life-threatening allergic reactions ...